デフォルト表紙
市場調査レポート
商品コード
1706821

リボ核酸(RNA)シーケンスの世界市場レポート 2025年

Ribonucleic Acid (RNA) Sequencing Global Market Report 2025


出版日
ページ情報
英文 200 Pages
納期
2~10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
リボ核酸(RNA)シーケンスの世界市場レポート 2025年
出版日: 2025年04月01日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

リボ核酸(RNA)シーケンス市場規模は、今後数年で飛躍的な成長が見込まれます。2029年にはCAGR22.3%で89億1,000万米ドルに成長します。予測期間の成長は、疾患の迅速かつ正確な診断に対する需要の高まり、リアルタイムポリメラーゼ連鎖反応の採用拡大、迅速かつオンサイトの診断検査に対する需要の高まり、感染症アウトブレイクの増加、コンパニオン診断薬に対する需要に起因すると考えられます。予測期間における主な動向には、疾病の検出とモニタリング、創薬、標的の検証、バイオマーカーの同定、DNAシーケンス技術、診断検査の進歩、次世代シーケンス(NGS)、マイクロ流体工学、ラボオンチッププラットフォーム、高度な分子診断ソリューション開発などが含まれます。

リボ核酸(RNA)シーケンス市場の成長軌道は、精密医療への重点の高まりによって推進されると予想されます。個別化医療としても知られる精密医療は、遺伝子、環境、ライフスタイルの個人差を考慮した、治療と予防への革新的なアプローチです。このアプローチは、ゲノミクスの進歩、疾病の複雑化、支援的な規制措置によって拍車がかかり、より効果的な治療を提供することが期待されています。RNA配列決定技術は、このような状況において重要な役割を果たし、RNA分子の配列決定とサンプル内の発現レベルの定量化を可能にします。このような技術はトランスクリプトームの包括的解析を容易にし、遺伝子発現パターン、代替スプライシングイベント、RNA修飾に関する洞察を提供します。注目すべきは、FDAが2024年2月に希少疾患患者向けに新規の個別化治療を16件承認したことです。その結果、精密医療への注目の高まりがリボ核酸(RNA)シーケンス市場拡大の原動力となっています。

リボ核酸(RNA)シーケンス市場では、主要企業はデータ主導の洞察と精密医療を通じて患者ケアを強化するために、RNA次世代シーケンスアッセイを優先しています。RNA次世代シーケンスアッセイは、高度なゲノムシーケンス技術を活用して患者のエクソーム全体を解析し、次世代エクソームシーケンスプラットフォームを代表します。例えば、米国のプレシジョン・メディシン・テクノロジー企業であるTempus社は、2023年6月、新しいスタンドアローンRNA次世代シーケンシングアッセイであるTempus xRを発表しました。この革新的なアッセイは固形がん向けに調整されており、トランスクリプトーム全体の包括的な解析を提供し、100以上の標的遺伝子における臨床的に重要な融合や、METエクソン14とEGFRvIIIのスプライシングの変化を同定します。このアッセイは、RNA融合やスプライシングの変化に特定の関心を持つ医師や、既存サンプルの詳細なRNAシーケンス解析を求める医療提供者、研究者、バイオ製薬企業向けに提供されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界リボ核酸(RNA)シーケンス PESTEL分析(政治、社会、技術、環境、法的要因、促進要因と抑制要因)
  • 最終用途産業の分析
  • 世界のリボ核酸(RNA)シーケンス市場:成長率分析
  • 世界のリボ核酸(RNA)シーケンス市場の実績:規模と成長, 2019-2024
  • 世界のリボ核酸(RNA)シーケンス市場の予測:規模と成長, 2024-2029, 2034F
  • 世界リボ核酸(RNA)シーケンス総アドレス可能市場(TAM)

第6章 市場セグメンテーション

  • 世界のリボ核酸(RNA)シーケンス市場:製品タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 機器
  • 試薬とキット
  • ソフトウェア
  • 世界のリボ核酸(RNA)シーケンス市場:技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 単一分子ベースのシーケンシング
  • シーケンスバイシンセシステクノロジー
  • ナノポアシーケンシング技術
  • イオントレント半導体シーケンシング
  • 世界のリボ核酸(RNA)シーケンス市場:用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 診断
  • 創薬
  • トランスレーショナルメディシン
  • その他の用途
  • 世界のリボ核酸(RNA)シーケンス市場:エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 調査と学術
  • 病院と診療所
  • 製薬およびバイオテクノロジー企業
  • その他のエンドユーザー
  • 世界のリボ核酸(RNA)シーケンス市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 次世代シーケンサー
  • マイクロアレイ機器
  • シングルセルRNAシーケンシング装置
  • 世界のリボ核酸(RNA)シーケンス市場試薬とキットの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • RNA抽出キット
  • RNAシーケンシングキット
  • 図書館準備キット
  • 世界のリボ核酸(RNA)シーケンス市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
  • データ分析ソフトウェア
  • データ管理ソフトウェア
  • バイオインフォマティクスソフトウェア

第7章 地域別・国別分析

  • 世界のリボ核酸(RNA)シーケンス市場:地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
  • 世界のリボ核酸(RNA)シーケンス市場:国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • リボ核酸(RNA)シーケンス市場:競合情勢
  • リボ核酸(RNA)シーケンス市場:企業プロファイル
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • GE HealthCare Technologies Inc
  • Eurofins Scientific SE
  • Agilent Technologies Inc
  • Illumina Inc
  • PerkinElmer Inc
  • bioMerieux SA
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc
  • QIAGEN N.V.
  • Tecan Genomics Inc
  • Natera Inc
  • Myriad Genetics Inc.
  • BGI Genomics Co Ltd
  • Takara Bio Inc

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • リボ核酸(RNA)シーケンス市場2029:新たな機会を提供する国
  • リボ核酸(RNA)シーケンス市場2029:新たな機会を提供するセグメント
  • リボ核酸(RNA)シーケンス市場2029:成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r31144

RNA sequencing, employing next-generation sequencing techniques, unveils the presence and abundance of RNA molecules within a biological specimen, offering a glimpse into gene expression dynamics. This methodology empowers scientists to delve into gene expression patterns, unearth novel transcripts, and decipher RNA processing mechanisms.

Within the realm of ribonucleic acid (RNA) sequencing, the primary product categories comprise instruments, reagents and kits, and software. Instruments encompass the tangible apparatuses utilized for RNA molecule analysis, encompassing sequencers and polymerase chain reaction devices, pivotal for accurate RNA sample processing and examination. Diverse technologies, including single molecule-based sequencing, sequence by synthesis, nanopore sequencing, and ion torrent semiconductor sequencing, find application across various sectors such as diagnostics, drug discovery, and translational medicine. End-users span research and academia, hospitals and clinics, pharmaceutical and biotechnology firms, among others.

The ribonucleic acid (RNA) sequencing market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (RNA) sequencing market statistics, including ribonucleic acid (RNA) sequencing industry global market size, regional shares, competitors with a ribonucleic acid (RNA) sequencing market share, detailed ribonucleic acid (RNA) sequencing market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (RNA) sequencing industry. This ribonucleic acid (RNA) sequencing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The ribonucleic acid (RNA) sequencing market size has grown exponentially in recent years. It will grow from $3.25 billion in 2024 to $3.98 billion in 2025 at a compound annual growth rate (CAGR) of 22.7%. The growth in the historic period can be attributed to rising number of drug development activities, growing prevalence of genetic disorders and target diseases, increasing use of miniaturized portable instruments, growing use of biomarker profiling, growing demand for personalized medicine, and the increasing number of cancer patients.

The ribonucleic acid (RNA) sequencing market size is expected to see exponential growth in the next few years. It will grow to $8.91 billion in 2029 at a compound annual growth rate (CAGR) of 22.3%. The growth in the forecast period can be attributed to rise in demand for rapid and accurate diagnosis of disease, growing adoption of real-time polymerase chain reaction, the growing demand for rapid and on-site diagnostic testing, rise in infectious disease outbreaks, and demand for companion diagnostics. Major trends in the forecast period include disease detection and monitoring, drug discovery, target validation, biomarker identification, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

The growth trajectory of the ribonucleic acid (RNA) sequencing market is expected to be propelled by an increasing emphasis on precision medicine. Precision medicine, also known as personalized medicine, represents an innovative approach to medical treatment and prevention, taking into account individual variability in genes, environment, and lifestyle. This approach holds promise for offering more effective treatments, spurred by advancements in genomics, the rising complexity of diseases, and supportive regulatory measures. RNA sequencing technologies play a crucial role in this landscape, enabling the determination of RNA molecule sequences and quantification of their expression levels within samples. Such technologies facilitate comprehensive analysis of transcriptomes, offering insights into gene expression patterns, alternative splicing events, and RNA modifications. Notably, in February 2024, the FDA approved 16 novel personalized therapies for patients with rare diseases, compared to six approvals in 2022, as reported by the Personalized Medicine Coalition. Consequently, the growing focus on precision medicine serves as a driving force behind the ribonucleic acid (RNA) sequencing market's expansion.

In the ribonucleic acid (RNA) sequencing market, key players prioritize RNA next-generation sequencing assays to enhance patient care through data-driven insights and precision medicine. RNA next-generation sequencing assays leverage advanced genomic sequencing technologies to analyze a patient's entire exome, representing a next-generation exome sequencing platform. For example, in June 2023, Tempus, a US-based precision medicine technology company, introduced its new standalone RNA next-generation sequencing assay, Tempus xR. This innovative assay, tailored for solid tumors, provides a comprehensive analysis of the entire transcriptome, identifying clinically significant fusions in over 100 targeted genes and altered splicing for MET Exon 14 and EGFRvIII. This offering caters to physicians with specific interests in RNA fusions or altered splicing, as well as to providers, researchers, and biopharma companies seeking detailed RNA sequencing analysis for their existing samples.

In January 2024, Parse Biosciences, a US-based biotechnology company focusing on developing innovative solutions for biological research and diagnostics, completed the acquisition of Biomage for an undisclosed sum. This acquisition enables Parse Biosciences to integrate Biomage's robust data analysis tools, including its Cellenics cloud-based platform, into Parse's Evercode combinatorial barcoding technology. Biomage Ltd., based in the UK, specializes in RNA sequencing and analysis software and services.

Major companies operating in the ribonucleic acid (RNA) sequencing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Eurofins Scientific SE, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Genomics Inc, Natera Inc, Myriad Genetics Inc., BGI Genomics Co Ltd, Takara Bio Inc, Cepheid, NeoGenomics Laboratories Inc, Abcam Limited, Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc, Macrogen Inc, Standard BioTools Inc, Ambry Genetics Corporation, Biocartis SA, CD Genomics.

North America was the largest region in the ribonucleic acid (RNA) sequencing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ribonucleic acid (RNA) sequencing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The ribonucleic acid (RNA) sequencing market consists of revenues earned by entities by providing services such as library preparation, RNA extraction, fragmentation, reverse transcription, adapter ligation, sequencing, data analysis, bioinformatics support, consultation and experimental design, quality control, sample preparation services, gene cloning, genotyping and mutation detection, and pathogen detection. The market value includes the value of related goods sold by the service provider or included within the service offering. The ribonucleic acid (RNA) sequencing market also includes sales of library preparation kits, RNA extraction kits, quantification kits, polymerase chain reaction (PCR) instruments, pipette tips, tubes, and plates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Ribonucleic Acid (RNA) Sequencing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ribonucleic acid (rna) sequencing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ribonucleic acid (rna) sequencing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ribonucleic acid (rna) sequencing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Instruments; Reagents And Kits; Software
  • 2) By Technology: Single Molecule Based Sequencing; Sequence By Synthesis Technology; Nanopore Sequencing Technology; Ion Torrent Semiconductor Sequencing
  • 3) By Applications: Diagnostics; Drug Discovery; Translational Medicine; Other Applications
  • 4) By End User: Research And Academia; Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Other End Users
  • Subsegments:
  • 1) By Instruments: Next-Generation Sequencers; Microarray Instruments; Single-Cell Rna Sequencing Instruments
  • 2) By Reagents And Kits: Rna Extraction Kits; Rna Sequencing Kits; Library Preparation Kits
  • 3) By Software: Data Analysis Software; Data Management Software; Bioinformatics Software
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton, Dickinson and Company
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Ribonucleic Acid (RNA) Sequencing Market Characteristics

3. Ribonucleic Acid (RNA) Sequencing Market Trends And Strategies

4. Ribonucleic Acid (RNA) Sequencing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Ribonucleic Acid (RNA) Sequencing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Ribonucleic Acid (RNA) Sequencing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Ribonucleic Acid (RNA) Sequencing Market Growth Rate Analysis
  • 5.4. Global Ribonucleic Acid (RNA) Sequencing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Ribonucleic Acid (RNA) Sequencing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Ribonucleic Acid (RNA) Sequencing Total Addressable Market (TAM)

6. Ribonucleic Acid (RNA) Sequencing Market Segmentation

  • 6.1. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Instruments
  • Reagents And Kits
  • Software
  • 6.2. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Molecule Based Sequencing
  • Sequence By Synthesis Technology
  • Nanopore Sequencing Technology
  • Ion Torrent Semiconductor Sequencing
  • 6.3. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery
  • Translational Medicine
  • Other Applications
  • 6.4. Global Ribonucleic Acid (RNA) Sequencing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research And Academia
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Companies
  • Other End Users
  • 6.5. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencers
  • Microarray Instruments
  • Single-Cell Rna Sequencing Instruments
  • 6.6. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Rna Extraction Kits
  • Rna Sequencing Kits
  • Library Preparation Kits
  • 6.7. Global Ribonucleic Acid (RNA) Sequencing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Analysis Software
  • Data Management Software
  • Bioinformatics Software

7. Ribonucleic Acid (RNA) Sequencing Market Regional And Country Analysis

  • 7.1. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Ribonucleic Acid (RNA) Sequencing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market

  • 8.1. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Ribonucleic Acid (RNA) Sequencing Market

  • 9.1. China Ribonucleic Acid (RNA) Sequencing Market Overview
  • 9.2. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Ribonucleic Acid (RNA) Sequencing Market

  • 10.1. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Ribonucleic Acid (RNA) Sequencing Market

  • 11.1. Japan Ribonucleic Acid (RNA) Sequencing Market Overview
  • 11.2. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Ribonucleic Acid (RNA) Sequencing Market

  • 12.1. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Ribonucleic Acid (RNA) Sequencing Market

  • 13.1. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Ribonucleic Acid (RNA) Sequencing Market

  • 14.1. South Korea Ribonucleic Acid (RNA) Sequencing Market Overview
  • 14.2. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Ribonucleic Acid (RNA) Sequencing Market

  • 15.1. Western Europe Ribonucleic Acid (RNA) Sequencing Market Overview
  • 15.2. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Ribonucleic Acid (RNA) Sequencing Market

  • 16.1. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Ribonucleic Acid (RNA) Sequencing Market

  • 17.1. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Ribonucleic Acid (RNA) Sequencing Market

  • 18.1. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Ribonucleic Acid (RNA) Sequencing Market

  • 19.1. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Ribonucleic Acid (RNA) Sequencing Market

  • 20.1. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market

  • 21.1. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market Overview
  • 21.2. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Ribonucleic Acid (RNA) Sequencing Market

  • 22.1. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Ribonucleic Acid (RNA) Sequencing Market

  • 23.1. North America Ribonucleic Acid (RNA) Sequencing Market Overview
  • 23.2. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Ribonucleic Acid (RNA) Sequencing Market

  • 24.1. USA Ribonucleic Acid (RNA) Sequencing Market Overview
  • 24.2. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Ribonucleic Acid (RNA) Sequencing Market

  • 25.1. Canada Ribonucleic Acid (RNA) Sequencing Market Overview
  • 25.2. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Ribonucleic Acid (RNA) Sequencing Market

  • 26.1. South America Ribonucleic Acid (RNA) Sequencing Market Overview
  • 26.2. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Ribonucleic Acid (RNA) Sequencing Market

  • 27.1. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Ribonucleic Acid (RNA) Sequencing Market

  • 28.1. Middle East Ribonucleic Acid (RNA) Sequencing Market Overview
  • 28.2. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Ribonucleic Acid (RNA) Sequencing Market

  • 29.1. Africa Ribonucleic Acid (RNA) Sequencing Market Overview
  • 29.2. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Ribonucleic Acid (RNA) Sequencing Market, Segmentation By Applications, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape And Company Profiles

  • 30.1. Ribonucleic Acid (RNA) Sequencing Market Competitive Landscape
  • 30.2. Ribonucleic Acid (RNA) Sequencing Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Becton, Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

31. Ribonucleic Acid (RNA) Sequencing Market Other Major And Innovative Companies

  • 31.1. GE HealthCare Technologies Inc
  • 31.2. Eurofins Scientific SE
  • 31.3. Agilent Technologies Inc
  • 31.4. Illumina Inc
  • 31.5. PerkinElmer Inc
  • 31.6. bioMerieux SA
  • 31.7. Beckman Coulter Inc
  • 31.8. Sysmex Corporation
  • 31.9. Bio-Rad Laboratories Inc
  • 31.10. QIAGEN N.V.
  • 31.11. Tecan Genomics Inc
  • 31.12. Natera Inc
  • 31.13. Myriad Genetics Inc.
  • 31.14. BGI Genomics Co Ltd
  • 31.15. Takara Bio Inc

32. Global Ribonucleic Acid (RNA) Sequencing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Ribonucleic Acid (RNA) Sequencing Market

34. Recent Developments In The Ribonucleic Acid (RNA) Sequencing Market

35. Ribonucleic Acid (RNA) Sequencing Market High Potential Countries, Segments and Strategies

  • 35.1 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Ribonucleic Acid (RNA) Sequencing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer